These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 22157277

  • 21. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW, Bijlsma JW.
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [Abstract] [Full Text] [Related]

  • 22. [Serious adverse effects of methotrexate therapy in patients with rheumatic arthritis].
    Purokivi M, Myllykangas-Luosujärvi R, Jantunen E.
    Duodecim; 1998; 114(21):2187-90. PubMed ID: 11757107
    [No Abstract] [Full Text] [Related]

  • 23. [Adverse effects of low-dose methotrexate therapy in rheumatoid arthritis].
    Furuya T, Totokawa S, Nakajima A, Suzuki T, Kashiwazaki S.
    Ryumachi; 1996 Oct; 36(5):746-52. PubMed ID: 8969553
    [Abstract] [Full Text] [Related]

  • 24. Benefit and risk of methotrexate treatment in rheumatoid arthritis.
    Rau R, Herborn G.
    Clin Exp Rheumatol; 2004 Oct; 22(5 Suppl 35):S83-94. PubMed ID: 15552520
    [Abstract] [Full Text] [Related]

  • 25. Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate.
    Biasi D, Bambara LM, Carletto A, Casaril M, Capra F, Caramaschi P, Corrocher R.
    J Rheumatol; 1996 Mar; 23(3):453-4. PubMed ID: 8832981
    [Abstract] [Full Text] [Related]

  • 26. Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis.
    Dervieux T, Zablocki R, Kremer J.
    Rheumatology (Oxford); 2010 Dec; 49(12):2337-45. PubMed ID: 20713496
    [Abstract] [Full Text] [Related]

  • 27. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A.
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [Abstract] [Full Text] [Related]

  • 28. Herpes zoster encephalomyelitis associated with low dose methotrexate for rheumatoid arthritis.
    Lyon CC, Thompson D.
    J Rheumatol; 1997 Mar; 24(3):589-91. PubMed ID: 9058671
    [Abstract] [Full Text] [Related]

  • 29. Association of methotrexate, rheumatoid arthritis, and melanoma in 2 patients.
    Jeannou J, Goupille P, Valat JP.
    J Rheumatol; 1997 Jul; 24(7):1444-5. PubMed ID: 9228153
    [No Abstract] [Full Text] [Related]

  • 30. Remission of a primary thyroid lymphoma after methotrexate withdrawal.
    de Mast Q, Haverman J, Netten PM, Sinnige HA.
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):716-7. PubMed ID: 16712679
    [No Abstract] [Full Text] [Related]

  • 31. [Effects of low dose methotrexate therapy in rheumatoid arthritis: a comparison of three different dosage regimens].
    Totokawa S, Furuya T, Nakajima A, Suzuki T, Kashiwazaki S.
    Ryumachi; 1997 Oct; 37(5):681-7. PubMed ID: 9396370
    [Abstract] [Full Text] [Related]

  • 32. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O, Gibofsky A.
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [Abstract] [Full Text] [Related]

  • 33. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.
    Wolfe F, Michaud K, Stephenson B, Doyle J.
    J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927
    [Abstract] [Full Text] [Related]

  • 34. Successful desensitization to low-dose methotrexate.
    Fernando SL.
    Rheumatology (Oxford); 2013 Dec; 52(12):2305-6. PubMed ID: 23681395
    [No Abstract] [Full Text] [Related]

  • 35. The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis.
    Sakai R, Komano Y, Tanaka M, Nanki T, Koike R, Nakajima A, Atsumi T, Yasuda S, Tanaka Y, Saito K, Tohma S, Fujii T, Ihata A, Tamura N, Kawakami A, Sugihara T, Ito S, Miyasaka N, Harigai M.
    Mod Rheumatol; 2011 Aug; 21(4):444-8. PubMed ID: 21312050
    [No Abstract] [Full Text] [Related]

  • 36. Progression of myelodysplasia during low-dose methotrexate therapy in rheumatoid arthritis.
    Murphy PT, Fay MJ, Swords RT, Quinn JP, O'Donnell JR.
    Ann Pharmacother; 2004 Nov; 38(11):1969-70. PubMed ID: 15454585
    [No Abstract] [Full Text] [Related]

  • 37. [Visceral leishmaniasis in two patients treated with methotrexate for rheumatoid arthritis].
    García Olid B, Guirao Arrabal E, Alcalá Díaz JF, Fernández de la Puebla RÁ.
    Enferm Infecc Microbiol Clin; 2012 Jan; 30(1):52. PubMed ID: 22079224
    [No Abstract] [Full Text] [Related]

  • 38. Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis.
    Vakily M, Amer F, Kukulka MJ, Andhivarothai N.
    J Clin Pharmacol; 2005 Oct; 45(10):1179-86. PubMed ID: 16172183
    [Abstract] [Full Text] [Related]

  • 39. The presence of HLA-DR B1 shared motif does not influence cyclophosphamide and methotrexate cytotoxicity in rheumatoid arthritis patients.
    Lacki JK, Wassmuth R, Korczowska I, Mackiewicz S, Muller W.
    J Investig Allergol Clin Immunol; 2000 Oct; 10(4):235-41. PubMed ID: 11039841
    [Abstract] [Full Text] [Related]

  • 40. [For parenteral gold therapy in rheumatoid arthritis].
    Wassenberg S.
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1676. PubMed ID: 21833891
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.